Jazz Pharmaceuticals plc (JAZZ) : Traders are bullish on Jazz Pharmaceuticals plc (JAZZ) as it has outperformed the S&P 500 by a wide margin of 3.56% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 6.42%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 6.35% in the last 1 week, and is up 7.04% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 6.49% and the 50-Day Moving Average is 3.62%. Jazz Pharmaceuticals Public Limited Company is up 0.18% in the last 3-month period. Year-to-Date the stock performance stands at 7.41%.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ): On Fridays trading session , Opening price of the stock was $152.82 with an intraday high of $153.73. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $149.45. However, the stock managed to close at $150.97, a loss of 1.21% for the day. On the previous day, the stock had closed at $152.82. The total traded volume of the day was 1,288,632 shares.